Tumor-induced osteomalacia (TIO)

Clinical trials for Tumor-induced osteomalacia (TIO) explained in plain language.

Never miss a new study

Get alerted when new Tumor-induced osteomalacia (TIO) trials appear

Sign up with your email to follow new studies for Tumor-induced osteomalacia (TIO), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Researchers track rare bone disease over years in observational study

Knowledge-focused Ongoing

This study follows 23 people with tumor-induced osteomalacia (TIO), a rare condition where tumors cause weak bones. The goal is to see how well the drug burosumab works over time and to monitor any tumor changes. Participants continue their usual care, and no new treatments are g…

Matched conditions: TUMOR-INDUCED OSTEOMALACIA (TIO)

Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Knowledge-focused

Last updated Jun 27, 2026 13:00 UTC

Tumor-induced osteomalacia (TIO)

Get alerted when new Tumor-induced osteomalacia (TIO) trials appear

Researchers track rare bone disease over years in observational study